Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
American Academy of Dermatology (AAD) 2023 Annual Meeting
March 17 - 21, 2023; New Orleans, Louisiana
March 17 - 21, 2023New Orleans, Louisiana
AAD 2023New Data Forecast More Oral PDE4 Inhibitors for PsoriasisA new oral phosphodiesterase-4 (PDE4) inhibitor achieved impressive rates of complete or near-complete skin clearance in a phase 2 study that also found the drug was well tolerated.
AAD 2023Dermatomyositis: Data Support IFN-Beta as Therapeutic TargetResponse rates in a phase 2 trial of a novel therapy for skin-predominant dermatomyositis were favorable in patients failed by at least one prior standard therapy, prompting plans for a phase 3 trial.
Medscape Medical News, March 20, 2023
Disclaimer: This coverage is not sanctioned by, nor a part of, the American Academy of Dermatology.
Clinical Clarity Grows About Toenail Disorder, Experts ReportThe hallmark of retronychia, a disorder of the toes, is layering of new nail growth under prior nail growth. The etiologies
vary, affecting treatment choice and likelihood of long-term response.
